Cigna (CI) Stock Forecast & Price Target

Compare

3,336 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CI Analyst Ratings

Strong Buy

15 Buy

4 Hold

0 Sell

Based on 19 analysts giving stock ratings to

Cigna

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CI Stock 12 Month Forecast

Average Price Target

$381.67

▲(20.78%Upside)

Based on 19 Wall Street analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is $381.67 with a high forecast of $407.00 and a low forecast of $341.00. The average price target represents a 20.78% change from the last price of $316.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"272":"$272","306":"$306","340":"$340","374":"$374","408":"$408"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":407,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$407.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":381.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$381.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":341,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$341.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[272,306,340,374,408],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,313.48,320.67384615384617,327.8676923076923,335.0615384615385,342.2553846153846,349.4492307692308,356.64307692307693,363.8369230769231,371.03076923076924,378.2246153846154,385.41846153846154,392.6123076923077,399.80615384615385,{"y":407,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,313.48,318.72538461538466,323.97076923076924,329.2161538461539,334.46153846153845,339.7069230769231,344.9523076923077,350.1976923076923,355.44307692307694,360.6884615384615,365.93384615384616,371.1792307692308,376.4246153846154,{"y":381.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,313.48,315.5969230769231,317.7138461538462,319.83076923076925,321.9476923076923,324.0646153846154,326.1815384615385,328.29846153846154,330.4153846153846,332.5323076923077,334.64923076923077,336.7661538461538,338.88307692307694,{"y":341,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":337.17,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":320.54,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":326.75,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":355.45,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":343.29,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":312.12,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":332.41,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":273.47,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":291.37,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":305.87,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":329.41,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":333.57,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":313.48,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$407.00

Average Price Target$381.67

Lowest Price Target$341.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$350

Buy

10.76%

Upside

Reiterated

06/24/25

Cigna's overall performance is bolstered by strong earnings growth and strategic initiatives, despite modest profitability and recent cash flow challenges. The technical analysis indicates stability without clear bullish or bearish momentum. Corporate confidence, as shown in recent events, supports the outlook.

Michael WiederhornOppenheimer

Oppenheimer

$375

Buy

18.67%

Upside

Reiterated

06/20/25

Cigna (CI) Gets a Buy from Oppenheimer

Stephen BaxterWells Fargo

Wells Fargo

$376→$341

Hold

7.91%

Upside

Reiterated

06/18/25

Wells Fargo Keeps Their Hold Rating on Cigna (CI)

Lance WilkesBernstein

Bernstein

$373

Hold

18.04%

Upside

Reiterated

06/17/25

Cigna (CI) Receives a Hold from Bernstein

Ben HendrixRBC Capital

RBC Capital

$371

Buy

17.41%

Upside

Reiterated

06/02/25

RBC Capital Keeps Their Buy Rating on Cigna (CI)

Andrew Mok CFABarclays

Barclays

$382→$385

Buy

21.84%

Upside

Assigned

06/02/25

Cigna price target raised to $385 from $382 at BarclaysCigna price target raised to $385 from $382 at Barclays

A.J. RiceUBS

UBS

$390

Buy

23.42%

Upside

Reiterated

05/23/25

UBS reiterates Buy Rating on CIGNA (CI)UBS analyst AJ Rice reiterated a Buy rating and $390.00 price target on CIGNA (NYSE: CI).

Jason CassorlaGuggenheim

Guggenheim

$388

Buy

22.78%

Upside

Reiterated

05/23/25

Guggenheim Sticks to Its Buy Rating for Cigna (CI)

David S MacdonaldTruist Financial

Truist Financial

$385→$405

Buy

28.16%

Upside

Reiterated

05/12/25

Cigna price target raised to $405 from $385 at TruistCigna price target raised to $405 from $385 at Truist

Lisa GillJ.P. Morgan

J.P. Morgan

―

Buy

―

Reiterated

05/06/25

Analysts Are Bullish on Top Healthcare Stocks: Corbus Pharmaceuticals (CRBP), Cigna (CI)

Paige MeyerCFRA

CFRA

$304→$392

Hold

24.05%

Upside

Downgraded

05/06/25

CFRA downgrades CIGNA (CI) to HoldCFRA analyst Paige Meyer downgraded CIGNA (NYSE: CI) from Buy to Hold with a price target of $392.00 (from $304.00).

Erin WrightMorgan Stanley

Morgan Stanley

$379→$390

Buy

23.42%

Upside

Reiterated

05/05/25

Cigna's Strategic Innovations and Financial Resilience Justify Buy Rating

David WindleyJefferies

Jefferies

$376→$397

Buy

25.63%

Upside

Reiterated

05/05/25

CIGNA (CI) PT Raised to $397 at JefferiesJefferies analyst David Windley raised the price target on CIGNA (NYSE: CI) to $397.00 (from $376.00) while maintaining a Buy rating.

John RansomRaymond James

Raymond James

$360→$385

Buy

21.84%

Upside

Reiterated

05/05/25

CIGNA (CI) PT Raised to $385 at Raymond JamesRaymond James analyst John Ransom raised the price target on CIGNA (NYSE: CI) to $385.00 (from $360.00) while maintaining a Strong Buy rating.

Whit MayoLeerink Partners

Leerink Partners

$325→$365

Hold

15.51%

Upside

Reiterated

05/05/25

Cigna's Balanced Risk/Reward Scenario: Strong Earnings with Cautious Outlook

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$350

Buy

10.76%

Upside

Reiterated

06/24/25

Michael WiederhornOppenheimer

Oppenheimer

$375

Buy

18.67%

Upside

Reiterated

06/20/25

Cigna (CI) Gets a Buy from Oppenheimer

Stephen BaxterWells Fargo

Wells Fargo

$376→$341

Hold

7.91%

Upside

Reiterated

06/18/25

Wells Fargo Keeps Their Hold Rating on Cigna (CI)

Lance WilkesBernstein

Bernstein

$373

Hold

18.04%

Upside

Reiterated

06/17/25

Cigna (CI) Receives a Hold from Bernstein

Ben HendrixRBC Capital

RBC Capital

$371

Buy

17.41%

Upside

Reiterated

06/02/25

RBC Capital Keeps Their Buy Rating on Cigna (CI)

Andrew Mok CFABarclays

Barclays

$382→$385

Buy

21.84%

Upside

Assigned

06/02/25

Cigna price target raised to $385 from $382 at BarclaysCigna price target raised to $385 from $382 at Barclays

A.J. RiceUBS

UBS

$390

Buy

23.42%

Upside

Reiterated

05/23/25

UBS reiterates Buy Rating on CIGNA (CI)UBS analyst AJ Rice reiterated a Buy rating and $390.00 price target on CIGNA (NYSE: CI).

Jason CassorlaGuggenheim

Guggenheim

$388

Buy

22.78%

Upside

Reiterated

05/23/25

Guggenheim Sticks to Its Buy Rating for Cigna (CI)

David S MacdonaldTruist Financial

Truist Financial

$385→$405

Buy

28.16%

Upside

Reiterated

05/12/25

Cigna price target raised to $405 from $385 at TruistCigna price target raised to $405 from $385 at Truist

Lisa GillJ.P. Morgan

J.P. Morgan

―

Buy

―

Reiterated

05/06/25

Analysts Are Bullish on Top Healthcare Stocks: Corbus Pharmaceuticals (CRBP), Cigna (CI)

Paige MeyerCFRA

CFRA

$304→$392

Hold

24.05%

Upside

Downgraded

05/06/25

CFRA downgrades CIGNA (CI) to HoldCFRA analyst Paige Meyer downgraded CIGNA (NYSE: CI) from Buy to Hold with a price target of $392.00 (from $304.00).

Erin WrightMorgan Stanley

Morgan Stanley

$379→$390

Buy

23.42%

Upside

Reiterated

05/05/25

Cigna's Strategic Innovations and Financial Resilience Justify Buy Rating

David WindleyJefferies

Jefferies

$376→$397

Buy

25.63%

Upside

Reiterated

05/05/25

CIGNA (CI) PT Raised to $397 at JefferiesJefferies analyst David Windley raised the price target on CIGNA (NYSE: CI) to $397.00 (from $376.00) while maintaining a Buy rating.

John RansomRaymond James

Raymond James

$360→$385

Buy

21.84%

Upside

Reiterated

05/05/25

CIGNA (CI) PT Raised to $385 at Raymond JamesRaymond James analyst John Ransom raised the price target on CIGNA (NYSE: CI) to $385.00 (from $360.00) while maintaining a Strong Buy rating.

Whit MayoLeerink Partners

Leerink Partners

$325→$365

Hold

15.51%

Upside

Reiterated

05/05/25

Cigna's Balanced Risk/Reward Scenario: Strong Earnings with Cautious Outlook

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cigna

1 Month

xxx

Success Rate

15/21 ratings generated profit

Average Return

+0.84%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 71.43% of your transactions generating a profit, with an average return of +0.84% per trade.

3 Months

xxx

Success Rate

21/30 ratings generated profit

Average Return

+6.23%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +6.23% per trade.

1 Year

Scott FidelStephens

Success Rate

21/27 ratings generated profit

Average Return

+19.18%

reiterated a buy rating 5 months ago

Copying Scott Fidel's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +19.18% per trade.

2 Years

xxx

Success Rate

17/18 ratings generated profit

Average Return

+26.67%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 94.44% of your transactions generating a profit, with an average return of +26.67% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CI Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CI has received 23 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. CI average Analyst price target in the past 3 months is 381.67.

Each month's total comprises the sum of three months' worth of ratings.

CI Financial Forecast

CI Earnings Forecast

Next quarter’s earnings estimate for CI is $7.14 with a range of $6.67 to $7.39. The previous quarter’s EPS was $6.74. CI beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.15% of the time in the same period. In the last calendar year CI has Outperformed its overall industry.

CI Sales Forecast

Next quarter’s sales forecast for CI is $62.49B with a range of $60.18B to $65.04B. The previous quarter’s sales results were $65.50B. CI beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.48% of the time in the same period. In the last calendar year CI has Outperformed its overall industry.

CI Stock Forecast FAQ

What is CI’s average 12-month price target, according to analysts?

Based on analyst ratings, Cigna Corp’s 12-month average price target is 381.67.

What is CI’s upside potential, based on the analysts’ average price target?

Cigna Corp has 20.78% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CI a Buy, Sell or Hold?

Cigna Corp has a consensus rating of Strong Buy which is based on 15 buy ratings, 4 hold ratings and 0 sell ratings.

What is Cigna Corp’s price target?

The average price target for Cigna Corp is 381.67. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $407.00 ,the lowest forecast is $341.00. The average price target represents 20.78% Increase from the current price of $316.

What do analysts say about Cigna Corp?

Cigna Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.

How can I buy shares of CI?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Cigna (CI) Stock Forecast & Price Target

CI Analyst Ratings

CI Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cigna

CI Analyst Recommendation Trends

CI Financial Forecast

CI Earnings Forecast

CI Sales Forecast

CI Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts